EV71 | CA16 | OE | p value | Total | |
---|---|---|---|---|---|
Total (n) | 89 | 68 | 20 | 177 | |
Gender (Male, n) | 52(58.4%) | 38(55.9%) | 14(70%) | 0.528 | 104(58.8%) |
Age*(Years) | 2.382 ± 2.102 | 2.588 ± 1.860 | 1.875 ± 1.146 | 0.347 | |
Region (from countryside, n) | 57(64%) | 41(60.3%) | 13(65%) | 0.868 | 111(62.3%) |
Time from onset to hospitalization (d) ② | 3.258 ± 1.176 | 4 ± 1.258 | 3.6 ± 1.353 | 0.001 | |
Duration of hospitalization (d) | 14.337 ± 17.796 | 9.338 ± 3.366 | 8.1 ± 3.354 | 0.182 | |
WBC > 12 × 10 9 (n) | 51(57.3%) | 32(47.1%) | 11(55%) | 0.437 | 94(530.1%) |
CRP > 8 mg/dl (n) | 4(4.5%) | 3(4.4%) | 1(5%) | 0.994 | 8(4.5%) |
Duration of initial fever(d) | 6.034 ± 3.131 | 5.706 ± 1.684 | 5.45 ± 1.468 | 0.547 | |
Highest fever temperature (°C) ③ | 39.144 ± 0.563 | 38.919 ± 0.494 | 38.92 ± 0.618 | 0.025 | |
Hand or foot rash (n) | 81(91%) | 67(98.5%) | 20(100%) | 0.057 | 168(94.9%) |
Oral rash (n) | 58(65.2%) | 50(73.5%) | 15(75%) | 0.451 | 123(69.5%) |
Buttock rash (n) | 39(43.8%) | 28(41.2%) | 6(30%) | 0.525 | 73(41.2%) |
No rash (n) | 3(2.2%) | 0 | 0 | 0.221 | 3(1.7%) |
Accompanied nervous system damage | 65(73%) | 19(27.9%) | 8(40%) | 0.000 | 92(52%) |
Patients with dysfunction upon discharge (n) | 11(12.4%) | 1(1.5%) | 1(5%) | 0.030 | 13(7.3%) |
Death (n) | 5(7.3%) | 0 | 0 | 0.030 | 5(2.8%) |